Ebanga approved to treat Ebola in adult and paediatric patients
News
Amgen files KRAS inhibitor sotorasib with EMA
Submission supported by results from phase II CodeBreaK 100 study
AMO Pharma launches late-stage study of CMD candidate
REACH-CDM study was based on results of positive phase II data
Vicore Pharma’s C21 med shows promise in COVID-19 study
Drug is being studied in hospitalised COVID-19 patients
EU green light for Zogenix’s Fintepla
Oral solution approved to treat seizures associated with Dravet syndrome
Shionogi’s novel antibiotic added to UK’s pilot subscription reimbursement model
Payment for drug linked to value to NHS rather than volume used
MHRA approves Polyphor’s phase 1 trial of novel inhaled antibiotic
Murepavadin is being developed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis
EU nod for first long-acting HIV injectable treatment
Rekambys plus Vocabria authorised to treat HIV-1 infections in adults who are virologically suppressed
AZ, Amgen’s SOURCE trial misses primary endpoint
New medicine tezepelumab is being studied in severe asthma
Pfizer, BioNTech win EU authorisation for COVID-19 vaccine Comirnaty
Follows positive opinion issued by EMA’s CHMP
Roche’s faricimab hits the mark in diabetic macular edema study
Treatment demonstrated non-inferior visual acuity gains compared to Regeneron’s Eylea
Green light for AZ’s Tagrisso in early-stage lung cancer
EGFR-TKI approved in the US for early non-small cell lung cancer
Aimmune’s peanut allergy med Palforzia wins EU approval
Drug becomes first treatment for peanut allergy in the EU
US approves Moderna’s COVID-19 vaccine for emergency use
Company will immediately begin delivering doses to the US government
Scancell picks lead COVID-19 vaccine candidate
SN14 will be advanced through further development and clinical trials
